WO1998049329A1 - Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance - Google Patents
Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance Download PDFInfo
- Publication number
- WO1998049329A1 WO1998049329A1 PCT/EP1998/002242 EP9802242W WO9849329A1 WO 1998049329 A1 WO1998049329 A1 WO 1998049329A1 EP 9802242 W EP9802242 W EP 9802242W WO 9849329 A1 WO9849329 A1 WO 9849329A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fungicide
- plant
- plants
- expression
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Definitions
- the present invention relates to a method for producing fungicide-tolerant plants by expressing an exogenous one
- the invention further relates to the use of the corresponding nucleic acids coding for a polypeptide, an antibody or parts of an antibody with fungicide-binding properties in transgenic plants and the transformed in this way
- Transgenic plants 20 plants are called transgenic plants.
- Transgenic plants are currently used in various biotechnological areas. Examples are insect-resistant plants (Vaek et al. Plant Cell 5 (1987), 159-169), virus-resistant plants (Powell et al. Science 232 (1986), 738-743) and ozone-resistant plants.
- the herbicide tolerance is characterized by an increased type or level of tolerance of the plant or of parts of plants to the applied herbicide. This can be accomplished in various ways.
- the known methods are the use of a metabolism gene such as, for example, the pat gene in connection with glufosinate resistance (WO 8705629) or a target enzyme which is resistant to the herbicide, as in the case of enolpyruvylshikimate -3-phosphate synthase (WO 9204449), which is resistant to 5 glyphosate, and the use of a herbicide in cell and tissue culture for the selection of tolerant plant cells and resulting resistant plants such as acetyl CoA carboxylase Inhibitors described (US 5162602, US 5290696).
- Antibodies are proteins that are part of the immune system. Common to all antibodies is their spatial, globular structure, the structure of light and heavy chains as well as their basic ability to bind molecules or parts of a molecular structure with high specificity (Alberts et al., In: Molecular Biology of the Cell, 2nd edition 1990, VCH Verlag, ISBN 3-527-27983-0, 1198-1237). Because of these properties, antibodies have been used for a variety of tasks. A distinction is made here between the use of the antibodies in animal and human organisms that produce them, the so-called in-situ applications and the ex-situ applications, i.e. the use of the antibodies after isolation from the producing cells or organisms (Whitelam and Cockburn, TIPS Vol.1, 8 (1996), 268-272).
- hybrid somatic cell lines haemas
- somatic cell lines a source of antibodies against very specific antigens
- Köhler and Milstein Nature 256 (1975) 495-97.
- This process can be used to produce so-called monoclonal antibodies, which have a uniform structure and are generated by cell fusion.
- Spleen cells from an immunized mouse are fused with cells from a mouse myeloma. This creates hybridoma cells that proliferate indefinitely. At the same time, the cells secrete specific antibodies against the antigen with which the mouse was immunized.
- the spleen cells provide the ability to produce antibodies, while the myeloma cells contribute the unlimited growth ability and the continuous antibody secretion.
- each hybridoma cell is derived from a single B cell as a clone, all of the antibody molecules produced have the same structure, including the antigen binding site. This method has greatly promoted the use of antibodies, as antibodies with a single, known specificity and a homogeneous structure are now available indefinitely. Monoclonal antibodies are widely used in immunodiagnostics and as therapeutic agents.
- phage display method for producing antibodies has been around for a few years, in which the immune system and the various immunizations in the animal are bypassed.
- affinity and specificity of the antibody is tailored in vitro (Winter et al., Ann. Rev. Immunol. 12 (1994), 433-455; Hoogenboom TIBTech Vol 15 (1997), 62-70).
- Gene segments which contain the coding sequence of the variable region of antibodies, ie the antigen binding site are fused with genes for the coat protein of a bacteriophage. Then you infect bacterial with phages containing such fusion genes.
- the resulting phage particles now have envelopes with the antibody-like fusion protein, with the antibody-binding domain pointing outwards.
- the phage which contains the desired antibody fragment and specifically binds to a specific antigen can now be isolated from such a phage display library.
- Each phage isolated in this way produces a monoclonal, antigen-binding polypeptide which corresponds to a monoclonal antibody.
- the genes for the antigen binding site which are unique for each phage, can be isolated from the phage DNA and used to construct complete antibody genes.
- antibodies have been used, in particular, as an analytical means ex situ for the qualitative and quantitative detection of antigens. This includes the detection of plant constituents, herbicides or fungicides in drinking water (Sharp et al. (1991) ACS Symp Ser., 446 (Pestic. Resides Food Saf.) 87-95), soil samples (WO 9423018) or in plants or parts of plants, and the use of antibodies
- Antibodies formed by the plant are supplied to the body from plants or parts of plants suitable for consumption via the mouth, throat or digestive tract and cause effective immune protection. Furthermore, in plants
- the chemical control of fungi in agronomically important crops requires the use of highly selective fungicides without phytotoxic effects.
- the phytotoxic effect of fungicides can, for example, be based on an inhibition of plant growth, reduced photosynthetic performance and the associated reduced yield. In some cases
- the object of the present invention was to develop a novel, generally applicable, genetic engineering method for producing fungicide-tolerant transgenic plants.
- This object was surprisingly achieved by a method of expressing an exogenous polypeptide, antibody or parts of an antibody with fungicide-binding properties in the plants.
- a first object of the present invention relates to the production of a fungicide-binding antibody and the cloning of the associated gene or gene fragment.
- a suitable antibody is first generated that binds the fungicide. This can include by immunizing a vertebrate, usually a mouse, rat, dog, horse, donkey or goat with an antigen.
- the antigen is a fungicidally active compound that is linked or associated via a functional group to a higher molecular carrier such as bovine serum albumin (BSA), chicken egg white (ovalbumin), keyhole limpet hemocyanin (KLH) or other carriers.
- BSA bovine serum albumin
- ovalbumin chicken egg white
- KLH keyhole limpet hemocyanin
- This approach initially provides a polyclonal serum that contains antibodies with different specificities.
- the first approach uses the fusion of antibody-producing cells with cancer cells to form a hybridoma cell culture that constantly produces antibodies, which, by separating the clones it contains, ultimately leads to a homogeneous cell line that produces a defined monoclonal antibody.
- the cDNA for the antibody or parts of the antibody is isolated from such a monoclonal cell line.
- These cDNA sequences can then be cloned in expression cassettes and for functional expression in prokaryotic and eukaryotic Organisms, including plants, can be used.
- phage display banks to select antibodies that bind fungicide molecules and catalytically convert them into a product with non-fungicidal properties.
- Methods for producing catalytic antibodies are described in Janda et al., Science 275 (1997) 945-948, Chemical selection for catalysis in combinatorial Antibody libraries; Catalytic Antibodies, 1991, Ciba Foundation Symposium 159, Wiley-Interscience Publication.
- a fungicide-resistant plant can also be produced by cloning the gene of this catalytic antibody and expressing it in a plant.
- the invention particularly relates to expression cassettes, the coding sequence of which codes for a fungicide-binding polypeptide or its functional equivalent, and their use for producing a fungicide-tolerant plant.
- the nucleic acid sequence can e.g. be a DNA or a cDNA sequence.
- Coding sequences suitable for insertion into an expression cassette according to the invention are, for example, those which contain a DNA sequence from a hybridoma cell which codes for a polypeptide with fungicide-binding properties and which thus give the host resistance to certain fungicides.
- an expression cassette according to the invention also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
- an expression cassette according to the invention comprises a promoter upstream, ie at the 5 'end of the coding sequence, and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which are associated with the coding sequence in between are operatively linked to the polypeptide with fungicide-binding properties and / or transit peptide.
- An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
- sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the plasma membrane, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil - corpuscles or other compartments and translation enhancers such as the 5 'leadership sequence from the tobacco mosaic virus (Gallie et
- An expression cassette according to the invention is produced by fusing a suitable promoter with a suitable polypeptide DNA and preferably a DNA coding for a chloroplast-specific transit peptide and a polyadenylation signal inserted between the promoter and polypeptide DNA and a polyadenylation signal according to common recombination and cloning techniques, such as, for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
- sequences which ensure targeting in the apoplasts, plastids, the vacuole, in the plasma membrane, the mitochondrium, the endoplasmic reticulum (ER) or by a lack of corresponding operative sequences, ensuring that they remain in the compartment of formation, the cytosol (Kermode , Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER and in the cell wall has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792; Artsaenko et al., Plant J. 8 ( 1995) 745-750).
- the invention also relates to expression cassettes, the coding sequence of which codes for a fungicide-binding fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
- Chloroplast-specific transit peptides which are split off enzymatically from the fungicide-binding polypeptide part after transposition of the fungicide-binding polypeptide into the plant chloroplasts are particularly preferred.
- the transit peptide is particularly preferably derived from plastidic transketolase (TK) or a functional equivalent of this transit peptide (e.g. the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase).
- the polypeptide DNA or cDNA required for the production of expression cassettes according to the invention is preferably amplified with the aid of the polymerase chain reaction (PCR).
- PCR polymerase chain reaction
- Methods for DNA amplification by means of PCR are known, for example from Innis et al., PCR Protocols, A Guide to Methods and Applications, Academic Press (1990).
- the PCR-generated DNA fragments can expediently be checked by sequence analysis to avoid polymerase errors in constructs to be expressed.
- the inserted nucleotide sequence coding for a fungicide-binding polypeptide can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components. In general, synthetic nucleotide sequences with codons are generated which are preferred by plants
- the promoter and terminator regions according to the invention should expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence.
- the linker has 1 to 10, usually 1 to 8, preferably 2 5 to 6 restriction sites.
- the linker has a size of less than 100 bp, often less than 60 bp, but at least 5 bp within the regulatory ranges.
- the promoter according to the invention can be both native or homologous and foreign or heterologous to the host plant.
- the expression cassette according to the invention contains, in the 5 '-3' transcription direction, the promoter according to the invention, any sequence and a region for the transcriptional termination. Different termination areas are interchangeable. 5
- an expression cassette according to the invention is inserted as an insert in a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example sequences for replication or integration.
- Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology” (CRC Press), Chap. 6/7, p.71-119 (1993).
- Cloning techniques can be cloned the expression cassettes according to the invention into suitable vectors that allow their multiplication, for example in E. coli.
- suitable cloning vectors include pBR332, pUC series, M13mp series and pA-CYC184.
- Another object of the invention relates to the use of an expression cassette according to the invention for the transformation of plants, plant cells, plant tissues or parts of plants.
- the aim of the use is preferably to impart resistance to fungicides with phytotoxic activity.
- the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
- Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further object of the present invention.
- transformation The transfer of foreign genes into the genome of a plant is called transformation.
- the methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic approach with the gene cannon, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and Agrobacterium-mediated gene transfer. The methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu.Rev. Plant Physiol. Plant Molec.Biol.
- construct to be expressed is preferably cloned into a vector which is suitable for transcribing Agrobacterium tumefaciens form, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
- Agrobacteria transformed with an expression cassette according to the invention can then be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various bush, tree, nut and wine species, such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly importantly used in vines, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- crop plants such as cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various bush, tree, nut and wine species, such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly importantly used in vines, for example by bathing wounded
- Functionally equivalent sequences which encode a fungicide-binding polypeptide are, according to the invention, those sequences which, despite a different nucleotide sequence, still have the desired functions.
- Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon usage of a plant.
- a functional equivalent is understood to mean, in particular, natural or artificial mutations of an originally isolated sequence encoding the fungicide-binding polypeptide, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
- the present invention also encompasses those nucleotide sequences which are obtained by modification of this nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also the insertion of further restriction enzyme interfaces.
- Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
- artificial DNA sequences are suitable as long as, as described above, they impart the desired tolerance to fungicides to avoid phytotoxic effects on crop plants.
- Such artificial DNA sequences can be constructed, for example, by back-translation using molecular modeling Proteins that have fungicide-binding activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence in accordance with the codon usage 5 specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
- Sequences are to be called sequences which code for fusion proteins, part of the fusion protein being a non-vegetable fungicide-binding polypeptide or a functionally equivalent part thereof.
- the second part of the fusion protein may be 5, for example, another polypeptide having enzymatic activity or be an antigenic polypeptide sequence by means of which detection of scFvs expression is possible (for example myc-tag or his-tag).
- this is preferably a regulatory protein sequence, such as a signal or transit peptide, which directs the polypeptide with fungicide-binding properties to the desired site of action.
- the invention also relates to the expression products produced according to the invention and to fusion proteins composed of a transit peptide and a polypeptide with fungicide-binding properties.
- Resistance or tolerance in the context of the present invention means the artificially acquired resistance of plants to fungicides with phytotoxic activity. It includes the partial and, in particular, the complete insensitivity to these inhibitors for at least one generation of plants. 5
- the phytotoxic site of action of fungicides is generally the leaf tissue, so that leaf-specific expression of the exogenous fungicide-binding polypeptide can offer adequate protection.
- the phytotoxic effect of a fungicide need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant.
- constitutive expression of the exogenous fungicide-binding polypeptide is advantageous.
- inducible expression may also appear desirable.
- the efficacy of the transgenically expressed polypeptide with fungicide-binding properties can be determined, for example, in vitro by increasing the number of shoots on fungicide-containing medium using graduated series of concentrations or using seed germination tests.
- a fungicide tolerance of a test plant which has been modified in terms of type and amount can be tested in greenhouse experiments.
- the invention furthermore relates to transgenic plants, trans- ⁇ formed with an inventive expression cassette, as well as transgenic cells, tissue, parts and propagation material of such plants.
- Transgenic crop plants such as, for example, cereals, maize, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, potato, tobacco, tomato, rapeseed, alfalfa, Sa 3 lat and the various bush, tree, Nut and wine species such as coffee, fruit trees such as apple, pear or cherry, nut trees such as walnut or pecan and particularly important the vine.
- the transgenic plants, plant cells, tissue or parts can be treated with a fungicide with a phytotoxic effect which inhibits the plant enzymes, as a result of which the plants, cells, tissue or plant parts which have not been successfully transformed die or are damaged.
- suitable active ingredients are strobilurins, in particular 5 methyl methoxyimino- ⁇ - (o-tolyloxy) -o-tolylacetate (BAS 490F), and metabolites and functional derivatives of these compounds.
- BAS 490F 5 methyl methoxyimino- ⁇ - (o-tolyloxy) -o-tolylacetate
- the DNA inserted into the expression cassettes according to the invention and coding for a polypeptide with fungicide-binding properties can thus also be used as a selection marker.
- the present invention offers the advantage that, after induction of a selective resistance of the crop plant to fungicides having a phytotoxic effect, 5 such fungicides can also be used in these crops at higher application rates to control harmful fungi which would otherwise lead to plant damage.
- Compounds from the following groups can be mentioned as non-limiting examples of such fungicides with phytotoxic activity:
- Sulfur, dithiocarbamates and their derivatives such as ferridimethyldithiocarbamate, zinc dimethyldithiocarbamate, zinc ethylene bisdithiocarbamate, manganese ethylene bisdithiocarbamate, manganese zinc ethylenediamine bisdithiocarbamate, tetramethylthiammonodiaminodisulfate , Ammonia complex of zinc (N, N '-propylene-bis-dithiocarbamate), Zinc (N, N '-propylenebis-dithiocarbamate), N, N' -polypropylene-bis- (thiocarbamoyl) disulfide;
- Nitroderivate such as dinitro- (1-methylheptyl) phenylcrotonate, 2-sec-butyl-4, 6-dinitrophenyl-3, 3-dimethylacrylate, 2-sec-butyl-4, 6-dinitrophenyl-isopropyl carbonate, 5- Di-isopropyl nitro-isophthalate;
- Heterocyclic substances such as 2-heptadecyl-2-imidazoline acetate, 2,4-dichloro-6- (o-chloroanilino) -s-triazine, 0.0-diethyl-phthalimidophosphonothioate, 5-amino-l- [ bis- (dimethylamino) - phosphinyl] -3-phenyl-l, 2, 4-triazole, 2, 3-dicyano-l, -dithioanthraquinone, 2-thio-l, 3-dithiolo [4, 5-b] quinoxaline, l- (butylcarbamoyl) -2-benzimidazole-carbamic acid methyl ester, 2-methoxycarbonylamino-benzimidazole, 2- (furyl- (2)) -benzimidazole, 2- (thiazolyl- (4)) -benzimidazole, N- (1, 1, 2, 2-tetrachlor
- Amines such as 2, 6-dimethyl-N-tridecyl-morpholine or its salts, 2, 6-dimethyl-N-cyclododecyl-morpholine or its salts, N- [3- (p-tert-butylphenyl) -2 -methylpropyl] -cis-2, 6-dimethyl-morpholine, N- [3- (p-tert-butylphenyl) -2-methylpropyl] -piperidine, (8- (1, 1-dimethylethyl) -N- ethyl-N-propyl-1,4-dioxaspiro [4.5] decane-2-methanamine,
- Azoles such as 1- [2- (2,4-dichlorophenyl) -4-ethyl-l, 3-dioxolan-2-yl-ethyl] -IH-l, 2,4-triazole, 1- [2- (2nd , 4-dichlorophenyl) -4-n-propyl-1,3-dioxolan-2-yl-ethyl] -1H-1,2,4-triazole, N- (n-propyl) -N- ( 2, 4, 6-trichlorophenoxyethyl) -N '-imidazol-yl-urea, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1, 2, 4-triazol-l-yl) - 2-butanone, 1- (4-chlorophenoxy) -3, 3-dimethyl-l- (1H-1,2, 4-triazol-l-yl) -2-butanol, (2RS, 3RS) - 1-
- Strobilurins such as methyl-E-methoxyimino- [ ⁇ - (o-tolyloxy) -o-tolyl] acetate, methyl-E-2- ⁇ 2- [6- (2-cyanophenoxy) pyrimidine-4-yloxy ] -phenyl ⁇ -3-methoxyacrylate, methyl-E-methoxyimino- [ ⁇ - (2-phenoxyphenyl)] acetamide, methyl-E-methoxyimino- [ ⁇ - (2, 5-dimethylphenoxy) -o-tolyl] -acetamide,
- Anilinopyrimidines such as N- (4, 6-dimethylpyrimidin-2-yl) aniline, N- [4-methyl-6- (1-propynyl) pyrimidin-2-yl] aniline,
- Cinnamic acid amides such as 3- (4-chlorophenyl) -3- (3, 4-dimethoxyphenyl) acrylic morpholide, as well as various fungicides, such as dodecylguanidine acetate, 3- [3- (3, 5-dimethyl-2-oxycyclohexyl) -2 -hydroxyethyl] -glutarimide, N-methyl-, N-ethyl- (4-trifluoromethyl, -2- [3 ', 4' -dimethoxyphenyl] -benzoic acid amide, hexachlorobenzene, DL-methyl-N- (2, 6- dimethyl-phenyl) -N-furoyl (2) -alaninate, DL-N- (2, 6-dimethyl-phenyl) -N- (2'-methoxyacetyl) -alanine-methyl-ester, N- ( 2,6-dimethylphenyl) -N-chloroace
- FIG. 5 is not restricted to these:
- the bacterial strains used below (E. coli, XL-I Blue) ⁇ were obtained from Stratagene.
- the Agrobacterium strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850kan) was developed by Deblaere et al. (Nucl. Acids Res. 13 (1985) 4777).
- the agrobacterial strain LBA4404 (Clontech) or other 5 suitable strains can be used.
- the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBlues- script SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl Acids Res. 12 (1984) 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230) 0 .
- the sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from Pharmacia according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1977), 5463-5467).
- a 35S CaMV promoter was inserted as an EcoRI-Kpnl fragment (corresponding to nucleotides 6909-7437 of the Cauliflower mosaic virus (Franck et al. Cell 21 (1980) 285).
- the polyadenylation signal of gene 3 der T-DNA of the Ti plasmid pTiACH5
- nucleotides 11749-11939 was isolated as a PvuII-HindIII fragment and cloned between the SpHI-HindIII interface of the vector after addition of Sphl linkers to the PvuII interface .
- the plasmid pBinAR was formed (Höfgen and Willmitzer, Plant Science 66 (1990) 221-230).
- fungicides are not immunogenic, they have to be attached to a carrier material such as e.g. KLH can be coupled. If there is a reactive group in the molecule, this coupling can take place directly, otherwise a functional function is carried out during the synthesis of the fungicide.
- a carrier material such as e.g. KLH
- this modified carrier molecule e.g. Balb / c mice immunized. As soon as there is enough antibody in the serum to bind to the antigen in the ELISA (enzyme
- 35 linked immunosorbent assay 35 linked immunosorbent assay are detectable, the spleen cells of these animals are removed and fused with myeloma cells in order to cultivate hybrids.
- fungicide-modified BSA is also used as an antigen to distinguish the immune response against the hapten from the KLH response.
- Monoclonal antibodies are produced based on known methods, as described, for example, in “Practical Immunology”, Leslie Hudson and Frank Hay, Blackwell Scientific 5 Publications, 1989 or in “Monoclonal Antibodies: Principles and Practice", James Goding, 1983 , Academic Press, Inc., or in "A practical guide to monoclonal antibodies", J. Liddell and A. Cryer, 1991, John Wiley &Sons; or Achim Möller and Franz Emling "Monoconal antibodies against TNF and their use”. European patent EP-A260610.
- the starting point for the investigation was a monoclonal antibody that specifically recognizes the BAS 490F fungicide and also has a high binding affinity.
- the selected hybrid cell line is characterized in that the secreted monoclonal antibodies directed against the fungicide antigen BAS 490F have a high affinity and the specific sequences of the immunoglobulins are available (Berek, C. et al., Nature 316, 412- 418, 1985).
- This monoclonal antibody against BAS 490F 5 was the starting point for the construction of the single-chain antibody fragment (scFv-antiBAS 490F).
- mRNA was isolated from the hybridoma cells and rewritten into cDNA o.
- This cDNA served as a template for the amplification of the variable immunoglobulin genes VH and VK with the specific primers VH1 BACK and VH FOR-2 for the heavy chain and VK2 BACK and MJK5 FON X for the light chain (Clackson et al., Nature 352 , 624-628, 1991).
- the isolated variable immunoglobulin lines were the starting point for the construction of a single-chain antibody fragment (scFv-antiBAS 490F).
- scFv-antiBAS 490F single-chain antibody fragment
- three components VH, VK and a linker fragment were combined in a PCR reaction mixture and the scFv-antiBAS 49OF was amplified (Fig. 3).
- the functional characterization (antigen binding activity) of the constructed scFv-antiBAS 490F gene was carried out after expression in a bacterial system.
- the scFv-antiBAS 49OF was made using the method of Hoogenboom, H.R. et al., Nucleic Acids Research 19, 4133-4137, 1991 as a soluble antibody fragment in E. coli.
- the activity and the specificity of the constructed antibody fragment were checked in ELISA tests (Fig. 4).
- the scFv-antiBAS 490F gene was cloned downstream of the LeB4 promoter.
- the LeB4 promoter isolated from Vicia faba shows a strictly seed-specific expression of various foreign genes in tobacco (Bäumlein, H. et al., Mol. Gen. Genet. 225, 121-128, 1991).
- the scFv For this purpose, the antiBAS 490F gene was merged with a signal peptide sequence that fuses entry into the endoplasmic reticulum and the ER retention signal SEKDEL, which ensures that it remains in the ER (Wandelt et al., 1992) (Fig. 5). 5
- the constructed expression cassette was cloned into the binary vector pGSGLUC 1 (Saito et al., 1990) and transferred into the Agrobacterium strain EHA 101 by electroporation. Recombinant agrobacterial clones were used for the subsequent transformation of x "Nicotiana tabacum. 70-140 tobacco plants were regenerated per construct. From the regenerated transgenic tobacco plants, seeds of various developmental stages were harvested after self-fertilization. From these seeds, the soluble proteins were obtained after extraction in an aqueous buffer system -
- the constructed scFv-antiBAS 490F gene had a size of approx.
- variable domains were fused together in the order VH-L-VL.
- the starting point for the investigations was a single chain antibody fragment against the fungicide BAS 490F (scFv-anti BAS 490F).
- the functional characterization (antigen binding activity) of this constructed scFv-anti-BAS 490F gene was carried out after expression 0 in a bacterial system and after expression in tobacco leaves. The activity and the specificity of the antibody fragment constructed was checked in ELISA tests.
- the scFv-antiBAS 490F gene was cloned downstream of the USP promoter.
- the soluble proteins were obtained after extraction in an aqueous buffer system. Subsequent analyzes (Western blot analyzes and ELISA tests) showed that a maximum accumulation of greater than 2% of biologically active, antigen-binding scFv-antiBAS 490F polypeptide could be achieved in the leaves. The high expression values were determined in adult green leaves, but the antibody fragment could also be detected in senescent leaf material.
- the PCR amplification of the one-chain antibody cDNA was carried out in a DNA thermal cycler from Perkin Elmer.
- the reaction mixtures contained 8 ng / ⁇ l of single-stranded template 20 cDNA, 0.5 ⁇ M of the corresponding oligonucleotides,
- Vector pBluescript was ligated. E. coli XL-I Blue was transformed with the ligation mixture and the plasmid was amplified.
- E. coli XL-I Blue was transformed with the ligation mixture and the plasmid was amplified.
- the plasmid pGSGLUC 1 was transformed into Agrobacterium tumefaciens 5 C58Cl: pGV2260.
- tobacco plants Naturala tabacum cv. Samsun NN
- a 1:50 dilution of an overnight culture of a positively transformed agrobact colony in Murashige-Skoog medium Physiol. Plant. 15 (1962) 473 ff.
- 2% sucrose (2MS medium 2% sucrose (2MS medium.
- Leaf disks of sterile plants (each about 1 cm 2 ) were incubated in a Petri dish with a 1:50 agrobacterial dilution for 5-10 minutes. This was followed by a 2-day incubation in the dark at 25 ° C.
- the starting point of the investigations was a single-chain antibody fragment expressed against the fungicide BAS 490F (scFv-anti BAS 490F) expressed in tobacco plants.
- the amount and activity of the synthesized scFv-antiBAS 490F polypeptide were determined in Western blot analyzes and ELISA tests.
- the foreign gene was controlled under the control of the CaMV 53S promoter as a translation fusion with the LeB4 signal peptide (N-th inal) and the ER retention signal KDEL (C- terminal).
- the scFv-antiBAS 490F polypeptide was transported into the endoplasmic reticulum, a stable accumulation of high amounts of active antibody fragment was achieved. After harvesting the leaf material, pieces were frozen at -20 ° C (1), lyophilized (2) or dried at room temperature (3).
- soluble proteins were obtained from the respective leaf material by extraction in an aqueous buffer and the scFv-antiBAS 490F polpypeptide was purified by affinity chromatography. Equal amounts of purified scFv-antiBAS 490F polypeptide (frozen, lyophilized and dried) were used to determine the activity of the antibody fragment (Fig. 6).
- Fig. 6 A shows the antigen binding activity of the fresh (1), lyophilized (2) and dried leaves (3) of purified scFv-antiBAS 490F polypeptides.
- Fig. 6 B the respective amounts of scFv-antiBAS 490F protein (about 100 ng), which were used for the ELISA analyzes, are determined by means of Western blot analyzes. The sizes of the protein molecular weight standards are shown on the left. Thereby about the same antigen binding activity was found.
- Control show a higher tolerance to the fungicide BAS 490F and lower phytotoxic effects.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98920534A EP0979295A1 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
SK1372-99A SK137299A3 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
PL98336661A PL336661A1 (en) | 1997-04-30 | 1998-04-16 | Expressions of polypeptides capable to bond fungicides in plants in order to produce fungicid tolerance by plants |
AU73356/98A AU737242B2 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for generating fungicide tolerance |
EA199900889A EA199900889A1 (en) | 1997-04-30 | 1998-04-16 | EXPRESSION OF CONNECTING FUNGICIDE POLYPEPTIDES IN PLANTS TO OBTAIN THEIR RESISTANCE TO FUNGICIDES |
IL13225298A IL132252A0 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
BR9808698-7A BR9808698A (en) | 1997-04-30 | 1998-04-16 | "processes for the production of a methoxyimino-alpha- (o-tolyloxy) -o-tolylacetate-tolerant plant (bas 490f), for the transformation of a plant and to control phytopathogenic fungi in culture plants tolerant to methoxyimino-alpha - Transgenic methyl (o-tolyloxy) -o-tolylacetate (bas 490f) plant expression cassette, plant expression cassette, uses of the expression cassette and a transformed plant, production of a methoxyimino-alpha binding polypeptide - (o-tolyloxy) -o-tolylacetate |
CA002288432A CA2288432A1 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
NZ500181A NZ500181A (en) | 1997-04-30 | 1998-04-16 | Production of methyl methoxyimino -alpha-(o-tolyloxy)-o-tolylacetate (BAS 490F)-tolerant plant by expressing the polypeptide |
JP54654298A JP2001523101A (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptide in plants to obtain fungicide resistance |
BG103840A BG103840A (en) | 1997-04-30 | 1999-10-28 | Fungicidebinding polypeptides expression in plants for forming tolerance to fungicides |
NO995291A NO995291L (en) | 1997-04-30 | 1999-10-29 | Expression of fungicide-binding polypeptides in plants to provide fungicide tolerance |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19718251A DE19718251A1 (en) | 1997-04-30 | 1997-04-30 | Expression of fungicide-binding polypeptides in plants to produce fungicide tolerance |
DE19718251.8 | 1997-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998049329A1 true WO1998049329A1 (en) | 1998-11-05 |
Family
ID=7828212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/002242 WO1998049329A1 (en) | 1997-04-30 | 1998-04-16 | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0979295A1 (en) |
JP (1) | JP2001523101A (en) |
KR (1) | KR20010020387A (en) |
CN (1) | CN1254381A (en) |
AR (1) | AR015626A1 (en) |
AU (1) | AU737242B2 (en) |
BG (1) | BG103840A (en) |
BR (1) | BR9808698A (en) |
CA (1) | CA2288432A1 (en) |
DE (1) | DE19718251A1 (en) |
EA (1) | EA199900889A1 (en) |
GE (1) | GEP20032959B (en) |
HU (1) | HUP0003594A3 (en) |
ID (1) | ID22915A (en) |
IL (1) | IL132252A0 (en) |
NO (1) | NO995291L (en) |
NZ (1) | NZ500181A (en) |
PL (1) | PL336661A1 (en) |
SK (1) | SK137299A3 (en) |
TR (1) | TR199902681T2 (en) |
WO (1) | WO1998049329A1 (en) |
ZA (1) | ZA983594B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002004020A2 (en) * | 2000-07-12 | 2002-01-17 | Mpb Cologne Gmbh | Pathogen resistance in organisms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0520962A2 (en) * | 1991-06-28 | 1992-12-30 | Ente per le nuove tecnologie, l'energia e l'ambiente ( ENEA) | Plasmid vectors for gene expression in plants |
WO1994023018A1 (en) * | 1993-03-29 | 1994-10-13 | Isk Biosciences Corporation | Immunoassay for tetrachloroisophthalonitrile (chlorothalonil®), its derivatives and breakdown products |
-
1997
- 1997-04-30 DE DE19718251A patent/DE19718251A1/en not_active Withdrawn
-
1998
- 1998-04-16 KR KR1019997010009A patent/KR20010020387A/en not_active Application Discontinuation
- 1998-04-16 GE GEAP19985103A patent/GEP20032959B/en unknown
- 1998-04-16 TR TR1999/02681T patent/TR199902681T2/en unknown
- 1998-04-16 WO PCT/EP1998/002242 patent/WO1998049329A1/en not_active Application Discontinuation
- 1998-04-16 IL IL13225298A patent/IL132252A0/en unknown
- 1998-04-16 NZ NZ500181A patent/NZ500181A/en unknown
- 1998-04-16 ID IDW991291A patent/ID22915A/en unknown
- 1998-04-16 BR BR9808698-7A patent/BR9808698A/en not_active IP Right Cessation
- 1998-04-16 HU HU0003594A patent/HUP0003594A3/en unknown
- 1998-04-16 EP EP98920534A patent/EP0979295A1/en not_active Withdrawn
- 1998-04-16 AU AU73356/98A patent/AU737242B2/en not_active Ceased
- 1998-04-16 EA EA199900889A patent/EA199900889A1/en unknown
- 1998-04-16 JP JP54654298A patent/JP2001523101A/en active Pending
- 1998-04-16 SK SK1372-99A patent/SK137299A3/en unknown
- 1998-04-16 CA CA002288432A patent/CA2288432A1/en not_active Abandoned
- 1998-04-16 PL PL98336661A patent/PL336661A1/en unknown
- 1998-04-16 CN CN98804679A patent/CN1254381A/en active Pending
- 1998-04-29 ZA ZA9803594A patent/ZA983594B/en unknown
- 1998-04-30 AR ARP980102047A patent/AR015626A1/en not_active Application Discontinuation
-
1999
- 1999-10-28 BG BG103840A patent/BG103840A/en unknown
- 1999-10-29 NO NO995291A patent/NO995291L/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0520962A2 (en) * | 1991-06-28 | 1992-12-30 | Ente per le nuove tecnologie, l'energia e l'ambiente ( ENEA) | Plasmid vectors for gene expression in plants |
WO1994023018A1 (en) * | 1993-03-29 | 1994-10-13 | Isk Biosciences Corporation | Immunoassay for tetrachloroisophthalonitrile (chlorothalonil®), its derivatives and breakdown products |
Non-Patent Citations (5)
Title |
---|
ARTSAENKO, O., ET AL.: "expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco", THE PLANT JOURNAL, vol. 8, no. 5, 1995, pages 745 - 750, XP002074417 * |
FIEDLER, U. AND CONRAD, U.: "High-level production and long-term storage of engineered antibodoes in trangenic tobacco seeds", BIOTECHNOLOGY, vol. 13, October 1995 (1995-10-01), pages 1090 - 1093, XP002074416 * |
HIATT A ET AL: "ASSEMBLY OF MULTIMERIC PROTEINS IN PLANT CELLS: CHARACTERISTICS AND USES OF PLANT-DERIVED ANTIBODIES", BOOKS IN SOILS PLANTS AND THE ENVIRONMENT: TRANSGENIC PLANTS: FUNDAMENTALS AND APPLICATIONS, 1 January 1993 (1993-01-01), pages 221 - 237, XP000569962 * |
SCHOUTEN A ET AL: "THE C-TERMINAL KDEL SEQUENCE INCREASES THE EXPRESSION LEVEL OF A SINGLE-CHAIN ANTIBODY DESIGNED TO BE TARGETED TO BOTH THE CYTOSOL AND THE SECRETORY PATHWAY IN TRANSGENIC TOBACCO", PLANT MOLECULAR BIOLOGY, vol. 30, 1996, pages 781 - 793, XP000677225 * |
SWAIN W F: "ANTIBODIES IN PLANTS", TRENDS IN BIOTECHNOLOGY, vol. 9, no. 4, 1 April 1991 (1991-04-01), pages 107 - 109, XP000207981 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002004020A2 (en) * | 2000-07-12 | 2002-01-17 | Mpb Cologne Gmbh | Pathogen resistance in organisms |
WO2002004020A3 (en) * | 2000-07-12 | 2002-07-18 | Mpb Cologne Gmbh | Pathogen resistance in organisms |
Also Published As
Publication number | Publication date |
---|---|
TR199902681T2 (en) | 2000-07-21 |
NO995291L (en) | 1999-12-20 |
ID22915A (en) | 1999-12-16 |
KR20010020387A (en) | 2001-03-15 |
JP2001523101A (en) | 2001-11-20 |
EP0979295A1 (en) | 2000-02-16 |
IL132252A0 (en) | 2001-03-19 |
BG103840A (en) | 2000-07-31 |
PL336661A1 (en) | 2000-07-03 |
DE19718251A1 (en) | 1998-11-05 |
CA2288432A1 (en) | 1998-11-05 |
HUP0003594A2 (en) | 2001-02-28 |
AU7335698A (en) | 1998-11-24 |
BR9808698A (en) | 2000-07-11 |
HUP0003594A3 (en) | 2002-10-28 |
AU737242B2 (en) | 2001-08-16 |
ZA983594B (en) | 1999-10-29 |
GEP20032959B (en) | 2003-04-25 |
NZ500181A (en) | 2001-02-23 |
AR015626A1 (en) | 2001-05-16 |
SK137299A3 (en) | 2000-05-16 |
CN1254381A (en) | 2000-05-24 |
NO995291D0 (en) | 1999-10-29 |
EA199900889A1 (en) | 2001-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637402T2 (en) | CHIMAIR GENE, CONTAINING A HYDROXY-PHENYLPYRUVATE DIOXYGENASE GENE ENCODING DNA SEQUENCE, AND PRODUCING THESE HERBICIDE RESISTANCES CONTAINING | |
DE69933713T2 (en) | Corn alpha-tubulin 3-18 promoter | |
DE60221051T2 (en) | PREPARATION OF PEPTIDES AND PROTEINS BY TREATMENT IN PROTEIN BODIES DERIVED FROM ENDOPLASMIC RETICULUM | |
Negrouk et al. | Highly efficient transient expression of functional recombinant antibodies in lettuce | |
DE102010013166A1 (en) | Method for increasing the yield of semen and promoting the growth of plants | |
DE69924005T2 (en) | TRANSGENIC PLANTS WITH CONDITIONAL LETHAL GEN | |
WO1997029200A1 (en) | Cassettes for the expression of storable proteins in plants | |
US5990385A (en) | Protein production in transgenic alfalfa plants | |
WO1998049329A1 (en) | Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance | |
DE69938144T2 (en) | ANTIBODY-MEDIATED DERIVATION REGULATION OF PLANT PROTEINS | |
EP0970231A1 (en) | Expression of herbicide-binding polypeptides in plants to produce herbicide tolerance | |
US20120042416A1 (en) | Antibody fusion-mediated plant resistance against Oomycota | |
DE10049267B4 (en) | Method for producing or increasing resistance in organisms to biotic stress factors | |
DE60314017T2 (en) | CHIMERIC PROTEIN CONTAINS THE CYSTEIN PROTEASE FROM THE LARGE LIVERGEL FUSIONED TO THE HEPATITIS B CORE PROTEIN OR UBIQUITIN; PLANTS EXPRESSING THIS PROTEIN, AND THEIR USE AS VACCINE | |
WO2003041493A1 (en) | Production of recombinant antibodies by means of fusion with elastin-like peptides | |
DE10145969A1 (en) | Method for producing a marker vaccine against a mammalian virus | |
CZ382199A3 (en) | Production of plants being tolerant to fungicides due to expression of polypeptides binding fungicides in plant | |
Mavituna | Production of recombinant human serum albumin in transgenic plants and plant cells | |
DE10063879B4 (en) | Nucleic acids encoding vacuolar invertases, plant cells and plants containing them and their use | |
KR0155453B1 (en) | Method of combined antibody against hepatitis-b virus by nicotiana tabacum | |
Junco et al. | International application published under the patent cooperation treaty (PCT) | |
EP1029064A1 (en) | Protein production in transgenic alfalfa plants | |
JP2001521756A5 (en) | ||
DE19604588A1 (en) | Cassette for expressing storage-stable proteins in plants | |
JPH06233685A (en) | Peptide gene of flower bud-inducing substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 132252 Country of ref document: IL Ref document number: 98804679.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL JP KR KZ LT LV MX NO NZ PL RO RU SG SI SK TR UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 137299 Country of ref document: SK Ref document number: 1998920534 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 500181 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/009498 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09403654 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2288432 Country of ref document: CA Ref document number: 2288432 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1999-3821 Country of ref document: CZ Ref document number: 1999/02681 Country of ref document: TR |
|
ENP | Entry into the national phase |
Ref document number: 1998 546542 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997010009 Country of ref document: KR Ref document number: 73356/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 199900889 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1998920534 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1999-3821 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997010009 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 73356/98 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998920534 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019997010009 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1999-3821 Country of ref document: CZ |